Tifluadom
Tifluadom[edit | edit source]
Tifluadom is a benzodiazepine derivative that acts as a selective opioid receptor agonist. It is primarily used in scientific research to study the opioid system and its effects on the central nervous system.
Chemical Properties[edit | edit source]
Tifluadom is characterized by its unique chemical structure, which includes a trifluoromethyl group. This structural feature contributes to its pharmacological activity and distinguishes it from other benzodiazepines. The presence of the trifluoromethyl group is believed to enhance its binding affinity to opioid receptors.
Mechanism of Action[edit | edit source]
Tifluadom acts as an agonist at the kappa-opioid receptors (KOR), which are one of the three main classes of opioid receptors, the others being mu and delta receptors. Activation of KOR by tifluadom leads to a variety of physiological effects, including analgesia, dysphoria, and diuresis.
Pharmacological Effects[edit | edit source]
The primary effects of tifluadom are mediated through its action on the kappa-opioid receptors. These effects include:
- Analgesia: Tifluadom produces pain relief by modulating the perception of pain in the central nervous system.
- Dysphoria: Unlike mu-opioid receptor agonists, kappa-opioid receptor agonists like tifluadom can induce feelings of unease or dysphoria.
- Diuresis: Tifluadom can increase urine production by affecting the renal system.
Research Applications[edit | edit source]
Tifluadom is used extensively in research to explore the role of kappa-opioid receptors in various physiological and pathological processes. Studies involving tifluadom have contributed to a better understanding of the opioid system and its potential therapeutic targets for conditions such as pain, addiction, and mood disorders.
Safety and Toxicity[edit | edit source]
As a research chemical, tifluadom is not approved for human use outside of controlled laboratory settings. Its safety profile in humans is not well-established, and it is primarily handled by trained professionals in research environments.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
